Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders

Background. High-dose chemotherapy (HDCT) with autologous hematopoietic stem cells transplantation (auto-HSCT) is an effective therapeutic option for patients with Hodgkin’s lymphoma and aggressive non-Hodgkin’s lymphomas in those cases, when the standard chemotherapy combined with the radiation the...

Full description

Bibliographic Details
Main Authors: VO Sarzhevskii, DS Kolesnikova, VYa Mel’nichenko
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2016-10-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
high-dose chemotherapy
autologous hematopoietic stem cells transplantation
cardiotoxicity
troponin
NT-proBNP
Online Access:http://bloodjournal.ru/en/biochemical-markers-of-cardiotoxicity-of-high-dose-chemotherapy-and-autologous-hematopoietic-stem-cell-transplantation-in-patients-with-malignant-lymphoproliferative-disorders/

Internet

http://bloodjournal.ru/en/biochemical-markers-of-cardiotoxicity-of-high-dose-chemotherapy-and-autologous-hematopoietic-stem-cell-transplantation-in-patients-with-malignant-lymphoproliferative-disorders/

Similar Items